I expect more upgrades will be coming as analysts make their picks for 2014. FTNT seems like a no brainer as the stock is selling at a 15% discount after announcing good earnings. When you throw in the fact that they are on the cutting edge of the security market at a time when security breaches are becoming quite common, you have a double reason to jump on board. IMHO.
What we heard before was outstanding. I see no reason why this update would be anything less. Companies don't do presentations to brag about bad news, they just issue a press release in the dark of night and hope nobody notices. Ha!
I believe the company said they will not take a long as last time to pick a new CFO. They probably did a comprehensive job search then and can rely on what they found. Provided the same candidates are still available, FTNT should be able to move sooner rather than later. Announcement of a new CFO should propel the stock higher. IMHO.
He has called politicians and private citizens all kind of names, and in most cases he has never even apologized. Well, at least in his case, when you look at his drug abuse, womanizing, etc., you can consider the legitimacy of the source. Luckily, the Cldx board is the only board that I visit that gets into all the political baloney. Couldn't resist responding to the blatant hypocrisy. Time to get back to research and making money. Good luck!
The fact that DCvax has a great toxicity profile tells me that it has great potential. Since you can combine it with just about any standard treatment and it is comparatively cheep to other treatments is also a big plus.
That's why I bought more yesterday. This company is still selling at fire sale prices and all the evidence we have so far tell us that there is no fire!
I agree with your logic. And who knows, maybe someone will come in and try to buy these guys. The longer FTNT's stock price stays at a depressed level, the more attractive it is as a takeover candidate. With all the cash the company is sitting on, they would be very easy to buy. I believe they have over $5 a share in cash and no debt. How much better can it get!
I bought a little more at the close on the dip. I don't think the Fed will taper until March at the earliest. At this price, FTNT is still selling at fire sale prices. If the jobs report is not exceptionally strong tomorrow, I would expect to see a pretty strong market rally.
Cover your short position if you actually trade and move on. Save yourself some money and stop wasting your time.
Tomorrow could be even better as the market gets comfortable with the fact that CFO leaving is not associated with any problems. The company apparently had indicated that their CFO search should proceed much faster than the last time. Maybe they passed over someone who they probably should have taken instead. Hopefully, he or she is still interested.
All bio-techs do this when they need money or the price is high. CLDX, which also has a treatment in development for GBM, just announced that they were issuing shares at a considerable discount. Check their message board to see how unhappy some of them are. CLDX has been flying high, but interestingly enough, the research comparisons I have seen have shown NWBO's DCvax has been performing better than CLDX's drug in the study trials. Bio-techs are tough to hold sometimes, but the rewards can be significant.
CI is still down about $5 a share. I believe he has a plan, but at this point, only he knows what he is thinking. I sold most of my shares before the last big drop, but I still lost big time. Luckily, I invested in a couple of stocks that jumped nicely. I'll hold on to my 500 shares just to see how CI plays this out. Good luck!
It is tough if you are holding a lot of shares. I own a considerable chunk, but I am trying not to overreact. Nothing has changed since I bought, and I believe NWBO is really on to something with their treatment regime. If trial results continue to come in as they have been in the past, this little dip will prove to be of no consequence. Since part of the drop is related to dilution, we at least don't have to worry about that for a while. The company was smart to issue shares when all their positive news was fresh in investors' minds. I would expect that the big boys who invested at 4.80 did their DD and liked what they saw and were told.
Could break $18 today if the market doesn't really turn south. Anyone who tried to short this after the announcement could soon feel some real pain.
I believe the placement has been completed. Bio-techs bounce around quite a bit and are subject to manipulation. I remembering buying a small bio-tech when one of the big investment brokers slammed it. I bought at a 35% discount. Within one week, BMY bought it at a 50% premium. They, like NWBO had a promising cancer treatment. NWBO's research, the trial results to date, oncologist's glowing reports, patient survival profiles, etc. have not changed. Many of my bio-tech holdings have taken a hit because the sector is out of favor. Once we enter the new year with ASCO and all the other research seminar presentations coming up, I expect NWBO will do fine.
Between shorts having to cover and investors looking for a bargain, I see no reason for FTNT to stay under $18. If the company hires a well respected CFO in the next couple of months, I expect $19 a share would not be out of reach.
Should intensify when the market strengthens.